Skip to main content
Top
Published in: Diagnostic Pathology 1/2019

Open Access 01-12-2019 | Amyloidosis | Short report

Improving sensitivity of amyloid detection by Congo red stain by using polarizing microscope and avoiding pitfalls

Authors: Ashraf El-Meanawy, Christopher Mueller, Kenneth A. Iczkowski

Published in: Diagnostic Pathology | Issue 1/2019

Login to get access

Abstract

Systemic amyloidosis is a devastating group of disorders for which there is no current cure. The treatment goal is to reduce the burden of amyloidogenic protein precursors. The treatment is only effective if applied early in the disease process before significant and irreversible end organ damage has taken place. Congo red is still the standard stain used in most histopathology laboratories to identify amyloid material in tissues. The identification of Congophilic amyloid material is challenging because of multiple interfering factors. Here we describe improved sensitivity of identifying Congophilic materials in histologic sections using a metallurgical polarized microscope specifically constructed for polarized microscopy. The microscope is equipped with strain-free optics, matching polarizers, dis-integrated compensators, and a circular mobile stage. Compared to a standard clinical microscope, this setup significantly improves sensitivity of identifying amyloid material in Congo red-stained slides. We also describe the deleterious effect of plastic coverslip which can interfere with the ability to examine the slides under polarized light. We present a series of 10 different patients who had cardiac, brain, and salivary gland biopsies that were either equivocal or deemed negative using a standard clinical microscope but were positive using the equipment described above. These samples were confirmed to be positive by other methods including electron microscopy. We conclude that use of the correct equipment is needed before ruling out amyloidosis in tissue sections.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kyle RA. Amyloidosis: a convoluted story. Br J Haematol. 2001;114(3):529–38.CrossRef Kyle RA. Amyloidosis: a convoluted story. Br J Haematol. 2001;114(3):529–38.CrossRef
2.
go back to reference Sipe JD, Benson MD, Buxbaum JN, Si I, Merlini G, Saraiva MJM, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 nomenclature guidelines. Amyloid. 2016;23(4):209–13.CrossRef Sipe JD, Benson MD, Buxbaum JN, Si I, Merlini G, Saraiva MJM, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 nomenclature guidelines. Amyloid. 2016;23(4):209–13.CrossRef
3.
go back to reference Esplin BL, Gertz MA. Current trends in diagnosis and Management of Cardiac Amyloidosis. Curr Probl Cardiol. 2013;38(2):53–96.CrossRef Esplin BL, Gertz MA. Current trends in diagnosis and Management of Cardiac Amyloidosis. Curr Probl Cardiol. 2013;38(2):53–96.CrossRef
4.
go back to reference Kyle RA, Greipp PR, Fallon WM. Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood. 1986;68(1):220.PubMed Kyle RA, Greipp PR, Fallon WM. Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood. 1986;68(1):220.PubMed
5.
go back to reference Maixnerova D, Jancova E, Skibova J, Rysava R, Rychlik I, Viklicky O, et al. Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011. J Nephrol. 2014. Maixnerova D, Jancova E, Skibova J, Rysava R, Rychlik I, Viklicky O, et al. Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011. J Nephrol. 2014.
6.
go back to reference Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt Sinai J Med. 2012;79(6):733–48.CrossRef Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt Sinai J Med. 2012;79(6):733–48.CrossRef
7.
go back to reference Adams D, Lozeron P, Lacroix C. Amyloid neuropathies. Curr Opin Neurol. 2012;25(5):564–72.CrossRef Adams D, Lozeron P, Lacroix C. Amyloid neuropathies. Curr Opin Neurol. 2012;25(5):564–72.CrossRef
8.
go back to reference Tamaki H, Naito Y, Lee-Kawabata M, Taniguchi Y, Hao H, Hirota S, et al. Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib. Int J Hematol. 2010;92(4):655–8.CrossRef Tamaki H, Naito Y, Lee-Kawabata M, Taniguchi Y, Hao H, Hirota S, et al. Sustained improvement in cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib. Int J Hematol. 2010;92(4):655–8.CrossRef
9.
go back to reference Decourt A, Gondouin B, Delaroziere JC, Brunet P. Sall+¬e M, Burtey S, et al. trends in survival and renal recovery in patients with multiple myeloma or light-chain amyloidosis on chronic dialysis. Clin J Am Soc Nephrol. 2016;11(3):431–41.CrossRef Decourt A, Gondouin B, Delaroziere JC, Brunet P. Sall+¬e M, Burtey S, et al. trends in survival and renal recovery in patients with multiple myeloma or light-chain amyloidosis on chronic dialysis. Clin J Am Soc Nephrol. 2016;11(3):431–41.CrossRef
10.
go back to reference Novak L, Cook WJ, Herrera GA, Sanders PW. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant. 2004;19(12):3050–3.CrossRef Novak L, Cook WJ, Herrera GA, Sanders PW. AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant. 2004;19(12):3050–3.CrossRef
11.
go back to reference Herrera GA, Joseph L, Gu X, Hough A, Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004;128(8):875–9.PubMed Herrera GA, Joseph L, Gu X, Hough A, Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004;128(8):875–9.PubMed
12.
go back to reference Bely M, Makovitzky J. Sensitivity and specificity of Congo red staining according to Romhànyi. Comparison with Puchtler’s or Bennhold's methods. Acta Histochem. 2006;108(3):175–80.CrossRef Bely M, Makovitzky J. Sensitivity and specificity of Congo red staining according to Romhànyi. Comparison with Puchtler’s or Bennhold's methods. Acta Histochem. 2006;108(3):175–80.CrossRef
13.
go back to reference Howie AJ, Brewer DB. Optical properties of amyloid stained by Congo red: history and mechanisms. Micron. 2009;40(3):285–301.CrossRef Howie AJ, Brewer DB. Optical properties of amyloid stained by Congo red: history and mechanisms. Micron. 2009;40(3):285–301.CrossRef
14.
go back to reference Makovitzky J, Richter S, Appel TR. Topooptical investigations and enzymatic digestions on tissue-isolated amyloid fibrils. Acta Histochem. 2006;108(3):193–6.CrossRef Makovitzky J, Richter S, Appel TR. Topooptical investigations and enzymatic digestions on tissue-isolated amyloid fibrils. Acta Histochem. 2006;108(3):193–6.CrossRef
15.
go back to reference Linke RP. Diagnosis of minimal amyloid deposits using the Congo red fluorescence method. In: Picken MD PFMDMDPhDAHMDG, editor. Amyloid and Related Disorders. Current Clinical Pathology. Humana Press; 2012. Linke RP. Diagnosis of minimal amyloid deposits using the Congo red fluorescence method. In: Picken MD PFMDMDPhDAHMDG, editor. Amyloid and Related Disorders. Current Clinical Pathology. Humana Press; 2012.
16.
go back to reference Shidham VB, Hunt B, Jaradeh SS, Barboi AC, Devata S, Hari P. Performing and processing FNA of anterior fat pad for amyloid. J Vis Exp. 2010;30(44):1747. Shidham VB, Hunt B, Jaradeh SS, Barboi AC, Devata S, Hari P. Performing and processing FNA of anterior fat pad for amyloid. J Vis Exp. 2010;30(44):1747.
17.
go back to reference Howie AJ. Apple-green birefringence? The bulletin of the Royal College of pathologists 2008;(144):263–266. Howie AJ. Apple-green birefringence? The bulletin of the Royal College of pathologists 2008;(144):263–266.
18.
go back to reference Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, et al. UK myeloma forum (UKMF) and Nordic myeloma study group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol. 2009;147(1):22–42.CrossRef Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, et al. UK myeloma forum (UKMF) and Nordic myeloma study group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol. 2009;147(1):22–42.CrossRef
19.
go back to reference Stangou AJ, Banner NR, Hendry BM, Rela M, Portmann B, Wendon J, et al. Hereditary fibrinogen a alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood. 2010;115(15):2998–3007.CrossRef Stangou AJ, Banner NR, Hendry BM, Rela M, Portmann B, Wendon J, et al. Hereditary fibrinogen a alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood. 2010;115(15):2998–3007.CrossRef
20.
go back to reference Gillmore JD, Booth DR, Rela M, Heaton ND, Rahman V, Stangou AJ, et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. QJM. 2000;93(5):269–75.CrossRef Gillmore JD, Booth DR, Rela M, Heaton ND, Rahman V, Stangou AJ, et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. QJM. 2000;93(5):269–75.CrossRef
21.
go back to reference Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998;65(7):918–25.CrossRef Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998;65(7):918–25.CrossRef
22.
go back to reference Desikan KR, Dhodapkar MV, Hough A, Waldron T, Jagannath S, Siegel D, et al. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leukemia Lymphoma. 1997;27(3–4):315–9.CrossRef Desikan KR, Dhodapkar MV, Hough A, Waldron T, Jagannath S, Siegel D, et al. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leukemia Lymphoma. 1997;27(3–4):315–9.CrossRef
23.
go back to reference Cabrera Q, Macro M, Hebert B, Cornet E, Collignon A, Troussard X. Epidemiology of monoclonal Gammopathy of undetermined significance (MGUS): the experience from the specialized registry of hematologic malignancies of Basse-Normandie (France). Cancer Epidemiol. 2014;38(4):354–6.CrossRef Cabrera Q, Macro M, Hebert B, Cornet E, Collignon A, Troussard X. Epidemiology of monoclonal Gammopathy of undetermined significance (MGUS): the experience from the specialized registry of hematologic malignancies of Basse-Normandie (France). Cancer Epidemiol. 2014;38(4):354–6.CrossRef
24.
go back to reference Agarwal A, Ghobrial IM. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease. Clin Cancer Res. 2013;19(5):985–94.CrossRef Agarwal A, Ghobrial IM. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease. Clin Cancer Res. 2013;19(5):985–94.CrossRef
25.
go back to reference Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc. 2010;85(10):933–42.CrossRef Wadhera RK, Rajkumar SV. Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc. 2010;85(10):933–42.CrossRef
26.
go back to reference Romhanyi G. Selective differentiation between amyloid and connective tissue structures based on the collagen specific topo-optical staining reaction with Congo red. Virchows Arch A Pathol Pathol Anat. 1971;354(3):209–22.CrossRef Romhanyi G. Selective differentiation between amyloid and connective tissue structures based on the collagen specific topo-optical staining reaction with Congo red. Virchows Arch A Pathol Pathol Anat. 1971;354(3):209–22.CrossRef
27.
go back to reference Romhanyi G, Deak G, Bukovinszky A. Collagen-specific topo-optical staining reaction with Congo red and its ultrastructural interpretation. Acta Morphol Acad Sci Hung. 1970;18(3):261–82.PubMed Romhanyi G, Deak G, Bukovinszky A. Collagen-specific topo-optical staining reaction with Congo red and its ultrastructural interpretation. Acta Morphol Acad Sci Hung. 1970;18(3):261–82.PubMed
28.
go back to reference Elghetany MT, Saleem A, Barr K. The Congo red stain revisited. Ann Clin Lab Sci. 1989;19(3):190–5.PubMed Elghetany MT, Saleem A, Barr K. The Congo red stain revisited. Ann Clin Lab Sci. 1989;19(3):190–5.PubMed
29.
go back to reference Bely M, Makovitzky J. Sensitivity and specificity of Congo red staining according to Romhanyi. Comparison with Puchtler’s or Bennhold's methods. Acta Histochem. 2006;108(3):175–80.CrossRef Bely M, Makovitzky J. Sensitivity and specificity of Congo red staining according to Romhanyi. Comparison with Puchtler’s or Bennhold's methods. Acta Histochem. 2006;108(3):175–80.CrossRef
Metadata
Title
Improving sensitivity of amyloid detection by Congo red stain by using polarizing microscope and avoiding pitfalls
Authors
Ashraf El-Meanawy
Christopher Mueller
Kenneth A. Iczkowski
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Amyloidosis
Published in
Diagnostic Pathology / Issue 1/2019
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-019-0822-4

Other articles of this Issue 1/2019

Diagnostic Pathology 1/2019 Go to the issue